Learn more about our upcoming Galas and Signature Events Learn More
DENVER, CO – The Melanoma Research Foundation (MRF) will host its 14th Annual Denver Gala on Thursday, September 18 at its new venue, Asterisk Denver. This year’s event...
Melanoma has been a part of my life since 2004. November 2004 I was diagnosed with Stage I cutaneous (skin) melanoma and in January 2008 I was diagnosed with ocular melanom...
Six years ago I noticed a dark line in my finger nail that continued to worsen over the course of the year. After my nail started lifting from the nail bed, I went to see m...
I was first diagnosed with melanoma in 1996. Thanks to my primary care doctor, who identified an irregular mole on my back during a routine physical, and my dermatologist, ...
The Melanoma Research Foundation (MRF) applauds the U.S. Food and Drug Administration for its commitment to protecting public health by proposing to prevent the use of indo...
Through the Melanoma Research Foundation’s #CUREOM Unite! Campaign, Ocular Melanoma Patients Help Fund and Review Research Grant Washington, DC – T...
#GivingTuesday is almost over but it’s not too late to give a gift to the Melanoma Research Foundation (MRF) to help stop melanoma in its path. Christy and Dan share why ...
Today is #GivingTuesday! Read why Carola Supports the MRF. Melanoma is one of the fastest growing cancers in the world. Today, however, people across the globe stand...
#GivingTuesday is TOMORROW! Join Sheila in Supporting the MRF. #GivingTuesday is in less than 24 hours! Your tax-deductible gift received on #GivingTuesday will help...
#GivingTuesday is TOMORROW, December 1! Join Graham in Supporting the MRF. During the holiday season, we are especially grateful for the children in our lives and th...
#GivingTuesday is Tuesday, December 1, 2015! Join Julie and Amelia in Supporting the MRF. #GivingTuesday is Tuesday, December 1 and your gift to the Melanoma Researc...
Ocular melanoma survivor Anne Marie Montijo reflects on the passing of Dr. Oliver Sacks and her own goal to live each day with a spirit of gratitude.
Today, the FDA approved the targeted therapy combination of vemurafenib (Zelboraf®) with cobimetinib (Cotellic) for people who have advanced or metastatic melanoma and who...
Sep 25, 2025 ET
